The p38 MAPK Pathway Is Required for Cell Growth Inhibition of Human Breast Cancer Cells in Response to Activin*
暂无分享,去创建一个
Serge Lemay | Jean-Jacques Lebrun | J. Lebrun | S. Lemay | Suhad Ali | Suhad Ali | Eftihia Cocolakis | E. Cocolakis
[1] R. Derynck,et al. Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4 , 1997, Molecular and cellular biology.
[2] K. Irie,et al. The oncoprotein Evi-1 represses TGF-β signalling by inhibiting Smad3 , 1998, Nature.
[3] Jeffrey L. Wrana,et al. Mechanism of activation of the TGF-β receptor , 1994, Nature.
[4] P. Dijke,et al. DPC4 (SMAD4) mediates transforming growth factor-β1 (TGF-β1) induced growth inhibition and transcriptional response in breast tumour cells , 1997, Oncogene.
[5] L Bibbs,et al. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. , 1994, Science.
[6] H. Lodish,et al. Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene. , 1998, Genes & development.
[7] J. Massagué,et al. Activation of signalling by the activin receptor complex , 1996, Molecular and cellular biology.
[8] M. Oren,et al. Involvement of p21WAF1/Cip1, CDK4 and Rb in activin A mediated signaling leading to hepatoma cell growth inhibition , 1997, Oncogene.
[9] J. Massagué,et al. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways , 1996, Nature.
[10] L. Mathews,et al. Characterization of type II activin receptors. Binding, processing, and phosphorylation. , 1993, The Journal of biological chemistry.
[11] W. Vale,et al. Regulation of transforming growth factor beta- and activin-induced transcription by mammalian Mad proteins. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[12] Yigong Shi,et al. Crystal Structure of a Smad MH1 Domain Bound to DNA Insights on DNA Binding in TGF-β Signaling , 1998, Cell.
[13] R. Treisman,et al. The p38 and ERK MAP kinase pathways cooperate to activate Ternary Complex Factors and c‐fos transcription in response to UV light. , 1996, The EMBO journal.
[14] Xiao-Fan Wang,et al. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Baker,et al. A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. , 1996, Genes & development.
[16] M. Arsura,et al. The inhibitory effects of transforming growth factor beta1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-kappaB/Rel expression. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[17] J. Hsuan,et al. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of hsp27 , 1994, Cell.
[18] P. Hoodless,et al. Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2. , 1998, Molecular cell.
[19] J. Massagué,et al. TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders , 2000, Cell.
[20] A. Choi,et al. Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells. Role of p38 kinase and Nrf2 transcription factor. , 2000, The Journal of biological chemistry.
[21] Naoto Ueno,et al. XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1–TAK1 in the BMP signaling pathway , 1999, The EMBO journal.
[22] Jiahuai Han,et al. Pro-inflammatory Cytokines and Environmental Stress Cause p38 Mitogen-activated Protein Kinase Activation by Dual Phosphorylation on Tyrosine and Threonine (*) , 1995, The Journal of Biological Chemistry.
[23] F. Pouliot,et al. Expression profile of agonistic Smads in human breast cancer cells: Absence of regulation by estrogens , 1999, International journal of cancer.
[24] P. Hoodless,et al. MADR2 Is a Substrate of the TGFβ Receptor and Its Phosphorylation Is Required for Nuclear Accumulation and Signaling , 1996, Cell.
[25] K. Irie,et al. Identification of a Member of the MAPKKK Family as a Potential Mediator of TGF-β Signal Transduction , 1995, Science.
[26] Jerry L. Adams,et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis , 1994, Nature.
[27] Michel Morange,et al. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins , 1994, Cell.
[28] R. Derynck,et al. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription , 1998, Nature.
[29] Jiahuai Han,et al. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms , 1995, Science.
[30] M. Reiss,et al. Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer. , 1998, Cancer research.
[31] K. Irie,et al. Purification and Identification of a Major Activator for p38 from Osmotically Shocked Cells , 1996, The Journal of Biological Chemistry.
[32] Z. Brown,et al. p38 MAPK signalling cascades in inflammatory disease. , 1999, Molecular medicine today.
[33] R. Brent,et al. Mxi2, a mitogen-activated protein kinase that recognizes and phosphorylates Max protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[34] H. Ichijo,et al. From receptors to stress-activated MAP kinases , 1999, Oncogene.
[35] Andrew D. Sharrocks,et al. Targeting of p38 Mitogen-Activated Protein Kinases to MEF2 Transcription Factors , 1999, Molecular and Cellular Biology.
[36] P. Donahoe,et al. Müllerian Inhibiting Substance Inhibits Breast Cancer Cell Growth through an NFκB-mediated Pathway* , 2000, The Journal of Biological Chemistry.
[37] S. Tashiro,et al. ATF-2 Is a Common Nuclear Target of Smad and TAK1 Pathways in Transforming Growth Factor-β Signaling* , 1999, The Journal of Biological Chemistry.
[38] K. Miyazono,et al. Signaling inputs converge on nuclear effectors in TGF-β signaling , 2000 .
[39] Minoru Watanabe,et al. Smad4 and FAST-1 in the assembly of activin-responsive factor , 1997, Nature.
[40] Takeshi Imamura,et al. TGF‐β receptor‐mediated signalling through Smad2, Smad3 and Smad4 , 1997 .
[41] J. Ninomiya-Tsuji,et al. The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway , 1999, Nature.
[42] A. Moustakas,et al. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[43] B. Williams,et al. p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons , 1999, The EMBO journal.
[44] C. Zuiani,et al. Human mammary gland and breast carcinoma contain immunoreactive inhibin/activin subunits: evidence for a secretion into cystic fluid. , 1999, European journal of endocrinology.
[45] R. Davis,et al. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway , 1996, Molecular and cellular biology.
[46] P. Cohen,et al. Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution. , 1998, Chemistry & biology.
[47] R. Derynck,et al. Receptor-associated Mad homologues synergize as effectors of the TGF-β response , 1996, Nature.
[48] K. Miyazono,et al. Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. , 1999, Science.
[49] E. Nishida,et al. Involvement of the p38 Mitogen-activated Protein Kinase Pathway in Transforming Growth Factor-β-induced Gene Expression* , 1999, The Journal of Biological Chemistry.
[50] R. Coombes,et al. Inhibitory effects of activin on the growth and morpholgenesis of primary and transformed mammary epithelial cells. , 1996, Cancer research.